Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 948.50 GBp
Change Today +6.00 / 0.64%
Volume 88.3K
CSRT On Other Exchanges
As of 11:35 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

consort medical plc (CSRT) Snapshot

943.50 GBp
Previous Close
942.50 GBp
Day High
960.50 GBp
Day Low
943.50 GBp
52 Week High
06/3/15 - 1,003 GBp
52 Week Low
10/21/14 - 650.00 GBp
Market Cap
Average Volume 10 Days
0.19 GBp
Shares Outstanding
20.12 GBp
Dividend Yield
Current Stock Chart for CONSORT MEDICAL PLC (CSRT)

Related News

No related news articles were found.

consort medical plc (CSRT) Related Businessweek News

No Related Businessweek News Found

consort medical plc (CSRT) Details

Consort Medical plc designs, develops, and manufactures specialty medical drug delivery devices and services to the pharmaceutical industry in the United Kingdom, the United States, Europe, and internationally. It operates through Bespak and Aesica segments. The company offers respiratory devices, including metered dose inhaler valves, dry powder inhalers, integrated dose counters, actuators, and nicotine inhalation devices; injectables devices, such as auto-injectors, needlefree injectors, and bolus delivery devices; nasal devices; and other devices comprising point-of-care diagnostics devices and medical check valves. It also provides active pharmaceutical ingredient contract development, formulation, and contract manufacturing services. In addition, the company manufactures anodised parts and pressings; and pharmaceutical ingredients, products, and packaging, as well as commercial services. Consort Medical plc was incorporated in 1946 and is based in Hemel Hempstead, the United Kingdom.

1,973 Employees
Last Reported Date: 07/29/15
Founded in 1946

consort medical plc (CSRT) Top Compensated Officers

Chief Executive Officer, Director, Member of ...
Total Annual Compensation: 1.1M GBP
Chief Financial Officer, Group Finance Direct...
Total Annual Compensation: 596.0K GBP
Compensation as of Fiscal Year 2015.

consort medical plc (CSRT) Key Developments

Consort Medical plc., 2015 Earnings Call, Jun 16, 2015

Consort Medical plc., 2015 Earnings Call, Jun 16, 2015

Consort Medical plc Proposes Final Dividend, Payable on 24 October 2015

Consort Medical plc announced that the Board is proposing an unchanged final dividend of 11.68 pence against 11.68 pence a year ago, making a total dividend for the year of 18.11 pence against 18.11 pence a year ago. It will be paid on 24 October 2015 to shareholders who are on the register on 19 September 2015.

Consort Medical plc announces Unaudited Consolidated Earnings Results for the Year Ended April 30, 2015

Consort Medical plc announced unaudited consolidated earnings results for the year ended April 30, 2015. For the year, the company reported revenue of GBP 184,825,000 against GBP 100,010,000 a year ago. Operating profit was GBP 8,164,000 against GBP 17,406,000 a year ago. Profit before tax was GBP 5,512,000 against GBP 16,140,000 a year ago. Profit for the financial year from continuing operations was GBP 6,262,000 against GBP 13,646,000 a year ago. Profit for the financial year from continuing operations before special items was 15.1 pence per diluted share against 40.5 pence per diluted share a year ago. Profit for the financial year was GBP 4,948,000 or 15.4 pence per basic share against GBP 12,968,000 or 41.5 pence per diluted share a year ago. Adjusted diluted earnings per ordinary share were 46.9 pence against 41.4 pence a year ago. Net cash inflow from operating activities was GBP 12,108,000 against GBP 13,771,000 a year ago. Purchases of property, plant and equipment were GBP 20,500,000 against GBP 16,134,000 a year ago. Purchases of intangible assets were GBP 178,000 against GBP 158,000 a year ago. Net debt came in just below GBP 100 million. EBITDA (before special items) was GBP 24.4 million against GBP 33.2 million a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSRT:LN 948.50 GBp +6.00

CSRT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Carclo PLC 141.00 GBp 0.00
Gerresheimer AG €61.91 EUR -0.149
Rexam PLC 538.50 GBp +4.00
West Pharmaceutical Services Inc $56.86 USD -0.23
View Industry Companies

Industry Analysis


Industry Average

Valuation CSRT Industry Range
Price/Earnings 62.8x
Price/Sales 2.7x
Price/Book 2.3x
Price/Cash Flow 35.6x
TEV/Sales 2.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONSORT MEDICAL PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at